ArticleMolecular cytogenetics2012
Molecular cytogenetic characterization of undifferentiated embryonal sarcoma of the liver: a case report and literature review.
Article in Molecular cytogenetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 25 citations in OpenAlex.
- Massive undifferentiated embryonal sarcoma: An unusual primary hepatic malignancy.Radiology case reports · 2025Article
- Rare Case of Undifferentiated Embryonal Sarcoma of the Liver that Contained an Adenocarcinoma Component.Surgical case reports · 2025Article
- Undifferentiated embryonic sarcoma of the adult liver with paraneoplastic syndrome: a case report.Translational cancer research · 2022Article
- Undifferentiated embryonal sarcoma of the liver occurring in an adolescent: a case report with genomic analysis.Surgical case reports · 2022Article
- Review
- Review
- Undifferentiated embryonal sarcoma of the liver in adults: Retrospective analysis of a case series and systematic review.Oncology letters · 2020Article
- Hepatic mesenchymal hamartoma and undifferentiated embryonal sarcoma of the liver: a pathologic review.Hepatic oncology · 2020Review
- CDKN1A-interacting zinc finger protein 1 is a novel biomarker for lung squamous cell carcinoma.Oncology letters · 2018Article
- Undifferentiated embryonal sarcoma of the liver with an unusual presentation: case report and review of the literature.Journal of gastrointestinal oncology · 2016Article
- The Role of Cdkn1A-Interacting Zinc Finger Protein 1 (CIZ1) in DNA Replication and Pathophysiology.International journal of molecular sciences · 2016Review
- Undifferentiated embryonal sarcoma of liver: a multi-institutional experience with 9 cases.International journal of clinical and experimental pathology · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Undifferentiated embryonal sarcoma of the liver (UESL) represents a heterogeneous group of tumors derived from mesenchymal tissues. Earlier cytogenetic studies in limited cases demonstrated that UESL is associated with a recurrent translocation t(11;19)(q11;q13.3-q13.4) or add(19)(q13.4). In this report, we present our array comparative genomic hybridization (aCGH), fluorescence in situ hybridization (FISH) findings, and a missense mutation of TP53 gene by DNA sequencing in a 19-year-old patient with UESL. The data were compared to laboratory findings reported by previous studies.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.